THE DONOWAY CENTER Pancreatic NanoKnife Tumor Ablation for Advanced and Oligo-Metastatic Pancreatic Cancer
If you are being treated for advanced or oligometastatic pancreatic cancer you may want to contact Dr. Robert Donoway at ATLAS ONCOLOGY in Hollywood, Florida. Dr Donoway is using multi-modality therapy combining Pancreatic NanoKnife Tumor Ablation with chemo-immunoradio therapy to treat advanced stage cancer patients from around the world after they have stopped responding to standard of care therapy and have been left with few options for further treatment. With over 32 years of experience performing pancreatic surgery in south Florida, Dr Donoway recognized that because of late diagnosis, up to 85% of patients treated for pancreatic cancer already had metastatic disease at the time of diagnosis. This fact limited the benefit many patients might receive from pancreatic surgery, which is problematic as surgery has been long held to be the only reproduceable therapy for cure; whereas in reality surgery is currently more likely Palliative in almost 80% of the cases. Recent evidence shows that when even advanced disease is treated aggressively in an integrated approach, incorporating NanoKnife surgery with chemotherapy and now supplemented with immunotherapy, long-term survivorship can be achieved, especially when compared to chemotherapy alone. Dr Donoway has been a pioneer in the use of pancreatic NanoKnife, especially for complex cases. During the past decade, patients from around the world have traveled to benefit from
this groundbreaking treatment by Dr Donoway, which is FDA approved. Dr Donoway also treats other advanced cancers, such as liver, Breast, and sarcomas, using NanoKnife Surgery based on its FDA approved guidelines. Patients experience a brief recovery, which means the patient can start chemotherapy and radiation that much sooner. Dr Donoway feels that “we are long overdue to revise our approach to treating Pancreatic Ca. The treatment history been largely unchanged for over 80 years and has just broken the 10% five year survivorship barrier. Only thru thinking outside the box will we accomplish the positive. Otherwise, all we’re doing is confirming Einstein‘s definition of insanity.” Dr Donoway is involved in ongoing research in identifying the best chemo-immuno therapy and sequencing to be used along with Pancreatic nanoKnife/IRE . Dr Donoway states, “the results so far have been very encouraging and we have begun using it for other select cancers. Among his longest survivors are now patients over nine years without evidence of cancer recurrence. In the past, without IRE they would have lived a little over a year, and so this technique opens a whole new avenue for treating those eligible patients in a more targeted fashion.” Dr Donoway has presented his results of pancreatic ablation at the recent annual meeting of the American Pancreatic Association. For more information about Dr Donoway and the pancreatic IRE/NanoKnife program call 954-986-6366 or visit www.atlasoncology.com
4000 Hollywood Boulevard • Presidential Circle • Suite 160 North • Hollywood, Florida 33021 Phone 954-986-6366 • Fax 954-986-4355 www.AtlasOncology.com
